Loading ...

Margie Byron

Rho

Senior Biostatistician

Assessment Group

Margaret_Byron@rhoworld.com

Work:

919-595-6454

Mobile:

919-287-3039

Address:

Rho

Committees:

,

Studies:

ITN034AI

-

Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis

ITN035AI

-

A Cooperative Clinical Study of Abatacept in Multiple Sclerosis

ITN051AI

-

Defining Immune Tolerance in ANCA-associated Vasculitis

ITN055AI

-

Rituximab and Belimumab for Lupus Nephritis

ITN059AI

-

Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris

ITN091AI

-

VIBRANT: VIB4920 for Active Lupus Nephritis

Bio:

Admin Links

Shortcuts

ITN Documents

Links